Effect of Metformin on Disease Progression in Patients With Cryptogenic Cirrhosis (NASH-related Cirrhosis) With Diabetes or Impaired Glucose Tolerance or Insulin Resistance
NACompletedINTERVENTIONAL
Enrollment
86
Participants
Timeline
Start Date
September 1, 2014
Primary Completion Date
December 31, 2015
Study Completion Date
December 31, 2015
Conditions
NASH Related Cirrhosis
Interventions
DRUG
Metformin
DRUG
Insulin
Trial Locations (1)
110070
Institute of Liver & Biliary Sciences, New Delhi
All Listed Sponsors
lead
Institute of Liver and Biliary Sciences, India
OTHER
NCT02234440 - Effect of Metformin on Disease Progression in Patients With Cryptogenic Cirrhosis (NASH-related Cirrhosis) With Diabetes or Impaired Glucose Tolerance or Insulin Resistance | Biotech Hunter | Biotech Hunter